Molecular analysis and anticancer properties of two identified isolates, Fusarium solani and Emericella nidulans isolated from Wady El-Natron soil in Egypt against Caco-2 (ATCC) cell line

Asian Pacific Journal of Tropical Biomedicine

Volumn 2, Issue 11, 2012, Pages 863-869

  Mohamed, Hala F ^a  

^a Al Azhar University   (Egypt)

Author keywords

Anticancer agent; Anticancer property; Caco 2; Cell line; Colon cancer; Fungi; Multiple sequence analysis; Phylogenetic tree

Indexed keywords

FUNGAL EXTRACT; INTERNAL TRANSCRIBED SPACER; PROTEIN P53; RNA 18S; ANTINEOPLASTIC AGENT; DRUG MIXTURE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL STRAIN CACO 2; COLON CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DETERMINATION; DRUG EFFECT; EGYPT; EMERICELLA; EMERICELLA NIDULANS; FUNGAL STRAIN; FUNGAL STRUCTURES; FUNGUS ISOLATION; FUSARIUM SOLANI; GENE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENETIC DISTANCE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; INTERNAL TRANSCRIBED SPACER REGION GENE; MOLECULAR PHYLOGENY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPIC VARIATION; PHYLOGENETIC TREE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; TUMOR SUPPRESSOR GENE; CACO 2 CELL LINE; CHEMISTRY; CLASSIFICATION; DRUG EFFECTS; DRUG MIXTURE; FUSARIUM; GENE EXPRESSION; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; PHARMACOLOGY; PHYLOGENY;

ANTINEOPLASTIC AGENTS; CACO-2 CELLS; COMPLEX MIXTURES; EGYPT; EMERICELLA; FUSARIUM; GENE EXPRESSION; HUMANS; PHYLOGENY; SOIL MICROBIOLOGY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84864992435     PISSN: 22211691     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2221-1691(12)60244-5     Document Type: Article

References (36)

1. American Joint Committee on Cancer Colon and rectum. AJCC cancer staging manual 2010, 143-164. Springer, New York. 7th ed. S.B. Edge, D.R. Byrd, C.C. Compton, A.G. Fritz, F.L. Greene, A. Trotti (Eds.).
2. American Cancer Society Cancer facts & figures 2012, American Cancer Society, Atlanta, Ga.
3. Raja M, Ravikumar S, Gnanadesigan M, Vijayaumar V In vitro antibacterial activity of diterpene and benzoxazole derivatives from Excoecaria agallocha L. Int J Biol Chem Sci 2010, 4(3):692. 70.
4. Boopathy NS, Kathiresan K Anticancer drugs from marine flora: an overview. J Oncol 2010.
5. Ravikumar S, Suganthi P, Moses FM Crude bioactive compounds of actinomycetes from Manakkudy mangrove sediment. J Pharm Res 2011, 4(3):877-879.
6. Garcia MA, Jamel EM, Ward MM, Center Y, Hao RL, Siegel RL, et al. Global cancer facts and figures 2007, The American Cancer Society, Atlanta.
7. Ravikumar S, Fredimoses M, Gnanadesigan M Anticancer property of sediment actinomycetes against MCF-7 and MDA-MB-231 cell lines. Asian Pac J Trop Biomed 2012, 1:92-96.
8. Olano C, Lombó F, Méndez C, Salas JA Improving production of bioactive secondary metabolites in actinomycetes by metabolic engineering. Metab Eng 2008, 10(5):281-292.
9. Mohamed H Exploiting genomics to identify secondary metabolic pathways in Aspergillus fumigates (Ph. D thesis) 2005, University of Sheffield.
10. Huang YJ, Wang JF, Li GL, Zheng ZH, Su WJ Antitumor and antifungal activities in endophytic fungi isolated from pharmaceutical plants Taxus mairei, Cephalataxus fortunei and Torreya grandis. FEMS Immunol Med Microbiol 2006, 31(2):85-167.
11. Sambuy Y, De Angelis I, Ranaldi G, Scarino ML, Stammati A, Zucco F The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell Biol Toxicol 2005, 21(1):1-26.
12. Smetanová L, Stêtinová V, Svoboda Z, Kvetina J Caco-2 cells, biopharmaceutics classification system (BCS) and biowaiver. Acta Medica (Hradec Kralove) 2011, 4(1):3-8.
13. Leonard F, Collnot EM, Lehr CM A three-dimensional coculture of enterocytes, monocytes and dendritic cells to model inflamed intestinal mucosa In vitro. Mol Pharm 2010, 7(6):2103-2119.
14. Alsner J, Jensen V, Kyndi M, Offersen BV, Vu P, Børresen-Dale AL, et al. A comparison between p53 accumulations determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients. Acta Oncol 2008, 47(4):600-607.
15. Liu W, Ip MM, Podgorsak MB, Das GM Disruption of estrogen receptor alpha-p53 interaction in breast tumors: a novel mechanism underlying the anti-tumor effect of radiation therapy. Breast Cancer Res Treat 2009, 115(1):43-50.
16. Varna M, Bousquet G, Plassa LF, Bertheau P, Janin A TP53 status and response to treatment in breast cancers. J Biomed Biotechnol 2011, 2011:284584.
17. Camerini A, Donati S, Viacava P, Siclari O, Puccetti C, Tartarelli G, et al. Evaluation of HER2 and p53 expression in predicting response to docetaxel-based first-line chemotherapy in advanced breast cancer. J Exp Clin Cancer Res 2011, 11:30-38.
18. National Center for Biotechnology Information The p53 tumor suppressor protein. Genes and disease. United States National Institutes of Health. [Online] [Accessed on 20 Mar, 2012]. http://www.ncbi.nlm.nih.gov/books/bv.fcgi?call=bv.View..ShowSection&rid=gnd.section.107.
19. Bergey DH, Holt JG Bergey's manual of determinative bacteriology. 9th ed 1994, Lippincott Williams & Wilkins, Baltimore.
20. Singh V, Praveen V, Khan F, Kant C, Tripathi M Phylogenetics of an antibiotic producing Streptomyces strain isolated from soil. Bioinformation 2009, 4(2):53-58.
21. Gerlier D, Thomasset N Use of MTT colorimetric assay to measure cell activation. J Immunol Methods 1986, 94:57-63.
22. Joseph S, Shanmugapriya S, Gandhimathi R, Kiran SG, Ravji RT, Natarajaseenivasan K, et al. Optimization and production of novel antimicrobial agents from sponge associated marine actinomycetes Nocardiopsis dassonvillei MA D08. Appl Microbiol Biotechnol 2009, 83:435-445.
23. Bundt M, Widmer F, Pesaro M, Zeyer J, Blaser P Biological 'hot spots' in soils. Soil Biol Biochem 2001, 33(6):729-738.
24. Xia H, Mao Q, Paulson HL, Davidson BL siRNA-mediated gene silencing In vitro and in vivo. Nat Biotechnol 2002, 20:1006-1010.
25. Harris N, Brill E, Shohat O, Prokocimer M, Wolf D, Arai N, et al. Molecular basis for heterogeneity of the human p53 protein. Mol Cell Biol 1986, 6(12):4650-4656.
26. Suffness M, Pezzuto JM Assay related to cancer drug discovery. Methods in plant biochemistry: assay for bioactivity 2009, 71-133. Academic Press, London. K. Hostettman (Ed.).
27. Quinn PJ, Markey BK, Leonard FC, Hartigan P, Fanning S, FitzPatrick ES Veterinary microbiology and microbial disease. 2nd ed 2011, John Wiley & Sons, Chichester, West Sussex, UK.
28. Brakhage AA, Schroeckh V Fungal secondary metabolites - Strategies to activate silent gene clusters. Fungal Genet Biol 2011, 48(1):15-22.
29. García MT, Blázquez MA, Ferrándiz MJ, Sanz MJ, Silva-Martín N, Hermoso JA, et al. New alkaloid antibiotics that target the DNA topoisomerase I of Streptococcus pneumoniae. J Biol Chem 2011, 286:6402-6413.
30. Anibou M, Chait A, Zyad A, Taourirt M, Ouhdouch Y, Benherref A Actinomycetes from Moroccan habitats: isolation and screening for cytotoxic activities. World J Microbiol Biotechnol 2008, 24:2019-2025.
31. Gulecha V, Sivakuma T Anticancer activity of Tephrosia purpurea and Ficus religiosa using MCF 7 cell lines. Asian Pac J Trop Med 2011, 4(7):526-529.
32. Kumar RS, Rajkapoor B, Perumal P In vitro and in vivo anticancer activity of Indigofera cassioides Rottl. Ex. DC. Asian Pac J Trop Med 2011, 4(5):379-385.
33. Meyer A, Todt C, Mikkelsen NT, Lieb B Fast evolving 18S rRNA sequences from Solenogastres (Mollusca) resist standard PCR amplification and give new insights into mollusk substitution rate heterogeneity. BMC Evol Biol 2010, 10:70.
34. Peay KG, Kennedy PG, Bruns TD Fungal community ecology: a hybrid beast with a molecular master. BioScience 2008, 58:799-810.
35. Garner CD, Starr JK, McDonough PL, Altier C Molecular identification of veterinary yeast isolates by use of sequence-based analysis of the D1/D2 region of the large ribosomal subunit. J Clin Microbiol 2010, 48(6):2140-2146.
36. Smit S, Widmann J, Knight R Evolutionary rates vary among rRNA structural elements. Nucleic Acids Res 2007, 35(10):3339-3354.